C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/74 (2006.01) A61K 31/44 (2006.01) A61K 31/505 (2006.01) C07D 213/26 (2006.01) C07D 213/38 (2006.01) C07D 213/65 (2006.01) C07D 213/70 (2006.01) C07D 213/73 (2006.01) C07D 213/82 (2006.01) C07D 213/89 (2006.01)
Patent
CA 2376061
Pharmaceutical compositions incorporate aryl substituted olefinic amine compounds. Representative compounds are (2S)-(4E)-N-methyl-5-[3-(5-isopropoxy- 1-oxopyridin)yl)]-4-penten-2-amine, (3E)-N-methyl-4-(3-(1-oxopyridin)yl)-3- buten-1-amine, (4E)-N-methyl-5-(3-(1-oxopyridin)yl)-4-penten-2-amine, (4E)-N- methyl-5-(3-(5-((carboxymethyl)oxy)pyridin)yl)-4-penten-2-amine, (3E)-N-methyl- 4-[3-(5-nitro-6-aminopyridin)yl]-3-buten-1-amine, (3E)-N-methyl-4-[3-(5-(N- benzylcarboxamido)pyridin)yl]-3-buten-1-amine(4E)-N-methyl-5-[5-(2- aminopyrimidin)yl]-4-penten-2-amine, (4E)-N-methyl-5-(3-(5-aminopyridin)yl)-4- penten-2-amine (3E)-N-methyl-4-(3-(5-isobutoxypyridin)yl)-3-buten-1-amine, (3E)-N-methyl-4-(3-(5-ethylthiopyridin)yl)-3-buten-1-amine, (4E)-N-methyl-5-(3- (5-trifluoromethylpyridin)yl)-4-penten-2-amine, (4E)-5-(3-(5- isopropoxypyridin)yl)-4-penten-2-amine, and (4E)-5-(3-(5-isopropoxypyridin)yl)- 4-penten-2-amine.
L'invention concerne des compositions pharmaceutiques comprenant des composés aminés oléfiniques à substitution aryle. Les composés représentatifs sont (2S)-(4E)-N-méthyl-5-[3-(5-isopropoxy-1-oxopyridine)yl)]-4-pentène-2-amine, (3E)-N-méthyl-4-(3-(1-oxopyridine)yl)-3-butène-1-amine, (4E)-N-méthyl-5-(3-(1-oxopyridine)yl)-4-pentène-2-amine, (4E)-N-méthyl-5-(3-(5-((carboxyméthyl)oxy)pyridine)yl)-4-pentène-2-amine, (3E)-N-méthyl-4-[3-(5-nitro-6-aminopyridine)yl]-3-butène-1-amine, (3E)-N-méthyl-4-[3-(5-(N-benzylcarboxamido)pyridine)yl]-3-butène-1-amine(4E)-N-méthyl-5-[5-(2-aminopyrimidine)yl]-4-penten-2-amine, (4E)-N-méthyl-5-(3-(5-aminopyridin)yl)-4-penten-2-amine (3E)-N-méthyl-4-(3-(5-isobutoxypyridine)yl)-3-butène-1-amine, (3E)-N-méthyl-4-(3-(5-éthylthiopyridine)yl)-3-butène-1-amine, (4E)-N-méthyl-5-(3-(5-trifluorométhylpyridine)yl)-4-pentène-2-amine, (4E)-5-(3-(5-isopropoxypyridine)yl)-4-pentène-2-amine, et (4E)-5-(3-(5-isopropoxypyridine)yl)-4-pentène-2-amine.
Bhatti Balwinder Singh
Byrd Gary Dwight
Caldwell William Scott
Dull Gary Maurice
Hadimani Srishailkumar Basawannappa
Robic
Targacept Inc.
LandOfFree
Pharmaceutical compositions and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1669660